Glucagonoma syndrome: a review and update on treatment

@article{John2016GlucagonomaSA,
  title={Glucagonoma syndrome: a review and update on treatment},
  author={A. John and R. Schwartz},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2016},
  volume={30}
}
  • A. John, R. Schwartz
  • Published 2016
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology
  • Glucagonoma syndrome is defined by the presence of an alpha‐cell secreting tumour of the pancreas, elevated levels of glucagon, and a characteristic rash called necrolytic migratory erythema (NME). NME is usually a specific and often initial finding of glucagonoma syndrome, but it may occur in other settings unassociated with an alpha‐cell pancreatic tumour (pseudoglucagonoma syndrome). Glucagonoma syndrome must be distinguished from pseudoglucagonoma syndrome. Prompt recognition of NME and… CONTINUE READING
    35 Citations
    Glucagonoma syndrome with severe erythematous rash
    • 3
    Diarrhea: a missed D in the 4D glucagonoma syndrome
    • 2
    • PDF
    Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition
    • 7
    Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema
    • 2
    Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features
    • 2
    Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome
    • 3

    References

    SHOWING 1-10 OF 76 REFERENCES
    Glucagonoma syndrome: A case report.
    • 18
    • PDF
    Glucagonoma syndrome: a case report with focus on skin disorders
    • 10
    • PDF
    Clinical and Metabolic Aspects of Glucagonoma
    • 82
    Metastatic glucagonoma.
    • 4
    Glucagonoma and pseudoglucagonoma syndromes
    • R. Schwartz
    • Medicine
    • International journal of dermatology
    • 1997
    • 40
    Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
    • 68